Dexlansoprazole – a new-generation proton pump inhibitor

Dexlansoprazole modified release (MR) is an R-enantiomer of lansoprazole and a new-generation proton pump inhibitor exhibiting high efficacy in the treatment of symptoms and lesions associated with erosive oesophagitis caused by gastroesophageal reflux disease (GERD). The dual release of the active...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzydło-Radomańska, Barbara, Radwan, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697039/
https://www.ncbi.nlm.nih.gov/pubmed/26759624
http://dx.doi.org/10.5114/pg.2015.56109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697039/
https://www.ncbi.nlm.nih.gov/pubmed/26759624
http://dx.doi.org/10.5114/pg.2015.56109

Ejemplares similares